[144] HealthStream Inc SEC Filing
Rhea-AI Filing Summary
Form 144 notice for HealthStream, Inc. (HSTM): an individual proposes to sell 2,000 shares of Common Stock08/27/2025.
The filing states the shares were acquired as an RSU award from the issuer on 01/08/2025, paid in full on that date, and the reported aggregate market value of the proposed sale is $56,000. The filer reports 29,641,207 shares outstanding and discloses no sales by the holder in the prior three months. The filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale via broker of vested RSUs; negligible market impact but required compliance disclosure.
The notice documents a planned sale of 2,000 shares valued at $56,000 through J.P. Morgan Securities on 08/27/2025. The shares were issued as RSUs on 01/08/2025 and paid in full the same day. No prior sales in the past three months are reported. Given the reported outstanding shares (29,641,207), this transaction represents a very small fraction of the float and is unlikely to affect market pricing. The filing meets Rule 144 disclosure requirements and includes the required insider attestation about material information.
TL;DR: Routine insider disposition under Rule 144; demonstrates regulatory compliance and transparency.
The document reflects a routine disposition of vested RSUs by a person whose relationship to the issuer is disclosed on the form. The use of an institutional broker and the attestation concerning material information align with standard governance and disclosure practices. No evidence in the filing indicates any governance or disclosure issues; the transaction appears procedural rather than a signal of material corporate change.